Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic.
about
Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Novel Mcl-1/Bcl-2 dual inhibit ...... a known two-face BH3 mimetic.
@en
Novel Mcl-1/Bcl-2 dual inhibit ...... a known two-face BH3 mimetic.
@nl
type
label
Novel Mcl-1/Bcl-2 dual inhibit ...... a known two-face BH3 mimetic.
@en
Novel Mcl-1/Bcl-2 dual inhibit ...... a known two-face BH3 mimetic.
@nl
prefLabel
Novel Mcl-1/Bcl-2 dual inhibit ...... a known two-face BH3 mimetic.
@en
Novel Mcl-1/Bcl-2 dual inhibit ...... a known two-face BH3 mimetic.
@nl
P2093
P2860
P356
P1476
Novel Mcl-1/Bcl-2 dual inhibit ...... a known two-face BH3 mimetic.
@en
P2093
Gaobo Chai
Keren Zhang
Pengchen Su
Xiangqian Li
Xiaoyan Yu
Zhichao Zhang
P2860
P356
10.1002/ARDP.201400296
P577
2015-01-13T00:00:00Z